Andrew C. Jackson - 20 May 2022 Form 4 Insider Report for Ra Medical Systems, Inc. (VTAK)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
24 May 2022, 16:33:57 UTC
Prior SEC filing
24 Nov 2021
Next SEC filing
01 Jun 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Andrew Jackson

Key filing fact

Andrew C. Jackson filed Form 4 for Ra Medical Systems, Inc. (VTAK) on 24 May 2022.

Key facts

  • This page summarizes Andrew C. Jackson's Form 4 filing for Ra Medical Systems, Inc. (VTAK).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 24 May 2022, 16:33.

Change

  • Previous filing in this sequence was filed on 24 Nov 2021.
  • Current net transaction value: -$410.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RMED transaction

Common Stock

Tax liability

Transaction value
$410
Shares
-1,361
Change %
-5.9%
Price
$0.3013
Shares after
21,680
Date
20 May 2022
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares withheld by the issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock awards. This is not an open market sale of securities.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .